Drug news
FDA approves Precision Spectra Spinal Cord Stimulator System (Boston Scientific) for treating Chronic Pain
The FDA has approved the Precision Spectra Spinal Cord Stimulator (SCS) System, from Boston Scientific, for treating Chronic Pain. The Precision Spectra System is the world's first and only SCS system with Illumina 3D software and 32 contacts, and is designed to provide improved pain relief to a wide range of patients who suffer from chronic pain. By providing 32 contacts and four lead ports�twice that of any other SCS system�the Precision Spectra System offers more coverage of the spinal cord for the management of Chronic Pain. The device is currently being studied in two multicentre trials: OPTIONS and MAP.